![Asparaginase Toxicities: Identification and Management in Patients With Acute Lymphoblastic Leukemia | ONS Asparaginase Toxicities: Identification and Management in Patients With Acute Lymphoblastic Leukemia | ONS](https://cjon.ons.org/sites/default/files/journal-images/Table1Huynh.png)
Asparaginase Toxicities: Identification and Management in Patients With Acute Lymphoblastic Leukemia | ONS
![Overall (A), induction (B) and postinduction (C) incidence of allergic... | Download Scientific Diagram Overall (A), induction (B) and postinduction (C) incidence of allergic... | Download Scientific Diagram](https://www.researchgate.net/publication/368513863/figure/fig1/AS:1104479348899840@1640339805550/Overall-A-induction-B-and-postinduction-C-incidence-of-allergic-reactions-sum-of.jpg)
Overall (A), induction (B) and postinduction (C) incidence of allergic... | Download Scientific Diagram
![Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia | Leukemia Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41375-024-02153-6/MediaObjects/41375_2024_2153_Fig2_HTML.png)
Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia | Leukemia
![(PDF) Alternative algorithm for L-asparaginase allergy in children with acute lymphoblastic leukemia | Selin Aytac - Academia.edu (PDF) Alternative algorithm for L-asparaginase allergy in children with acute lymphoblastic leukemia | Selin Aytac - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/51254812/mini_magick20190125-29589-yj8w4h.png?1548488833)
(PDF) Alternative algorithm for L-asparaginase allergy in children with acute lymphoblastic leukemia | Selin Aytac - Academia.edu
![Hypersensitivity Rates in Pediatric Patients Receiving Intravenous or Intramuscular Asparaginase Agents Hypersensitivity Rates in Pediatric Patients Receiving Intravenous or Intramuscular Asparaginase Agents](https://jhoponline.com/images/jhop/2020/Vol10-No1-Feb/hyper_table1.png)
Hypersensitivity Rates in Pediatric Patients Receiving Intravenous or Intramuscular Asparaginase Agents
![Algorithm for treatment with PEG-asparaginase (* = mean number of vials). | Download Scientific Diagram Algorithm for treatment with PEG-asparaginase (* = mean number of vials). | Download Scientific Diagram](https://www.researchgate.net/profile/Yves-Benoit-2/publication/293200044/figure/fig2/AS:530815080767488@1503567585632/Algorithm-for-treatment-with-PEG-asparaginase-mean-number-of-vials_Q320.jpg)
Algorithm for treatment with PEG-asparaginase (* = mean number of vials). | Download Scientific Diagram
![Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open–Cancer Horizons roundtable discussion - ScienceDirect Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open–Cancer Horizons roundtable discussion - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2059702920327022-gr1.jpg)
Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open–Cancer Horizons roundtable discussion - ScienceDirect
![Use of PEG-asparaginase in newly diagnosed adults with standard-risk acute lymphoblastic leukemia compared with E. coli-asparaginase: a retrospective single-center study | Scientific Reports Use of PEG-asparaginase in newly diagnosed adults with standard-risk acute lymphoblastic leukemia compared with E. coli-asparaginase: a retrospective single-center study | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsrep39463/MediaObjects/41598_2016_Article_BFsrep39463_Fig2_HTML.jpg)
Use of PEG-asparaginase in newly diagnosed adults with standard-risk acute lymphoblastic leukemia compared with E. coli-asparaginase: a retrospective single-center study | Scientific Reports
![AEA measurements and 95% CI over time in the groups; Allergic reaction... | Download Scientific Diagram AEA measurements and 95% CI over time in the groups; Allergic reaction... | Download Scientific Diagram](https://www.researchgate.net/publication/377779041/figure/fig3/AS:11431281220731238@1706586823970/AEA-measurements-and-95-CI-over-time-in-the-groups-Allergic-reaction-on-3rd-dose-4th.png)
AEA measurements and 95% CI over time in the groups; Allergic reaction... | Download Scientific Diagram
![Hypersensitivity reactions to asparaginase therapy in acute lymphoblastic leukemia: immunology and clinical consequences | Future Oncology Hypersensitivity reactions to asparaginase therapy in acute lymphoblastic leukemia: immunology and clinical consequences | Future Oncology](https://www.futuremedicine.com/cms/10.2217/fon-2021-1288/asset/images/medium/figure3.gif)
Hypersensitivity reactions to asparaginase therapy in acute lymphoblastic leukemia: immunology and clinical consequences | Future Oncology
![Proposed treatment algorithm after allergic reactions to front-line... | Download Scientific Diagram Proposed treatment algorithm after allergic reactions to front-line... | Download Scientific Diagram](https://www.researchgate.net/publication/51664328/figure/fig4/AS:493081637199875@1494571231536/Proposed-treatment-algorithm-after-allergic-reactions-to-front-line-native-E-coli-ASE-on.png)
Proposed treatment algorithm after allergic reactions to front-line... | Download Scientific Diagram
![Hypersensitivity to Pegylated E.coli asparaginase as first-line treatment in contemporary paediatric acute lymphoblastic leukaemia protocols: a meta-analysis of the Ponte di Legno Toxicity working group - ScienceDirect Hypersensitivity to Pegylated E.coli asparaginase as first-line treatment in contemporary paediatric acute lymphoblastic leukaemia protocols: a meta-analysis of the Ponte di Legno Toxicity working group - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0959804921012260-gr1.jpg)
Hypersensitivity to Pegylated E.coli asparaginase as first-line treatment in contemporary paediatric acute lymphoblastic leukaemia protocols: a meta-analysis of the Ponte di Legno Toxicity working group - ScienceDirect
![Intravenous pegylated asparaginase versus intramuscular native Escherichia coli l-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial - ScienceDirect Intravenous pegylated asparaginase versus intramuscular native Escherichia coli l-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1470204515003630-gr1.jpg)
Intravenous pegylated asparaginase versus intramuscular native Escherichia coli l-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial - ScienceDirect
![Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia | Leukemia Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia | Leukemia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41375-024-02153-6/MediaObjects/41375_2024_2153_Fig1_HTML.png)
Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia | Leukemia
![A Retrospective Chart Review on the Toxicity of Pegylated Asparaginase in Adult Patients with Acute Lymphoblastic Leukemia A Retrospective Chart Review on the Toxicity of Pegylated Asparaginase in Adult Patients with Acute Lymphoblastic Leukemia](https://jhoponline.com/images/jhop/june2014/pg45_table4.png)
A Retrospective Chart Review on the Toxicity of Pegylated Asparaginase in Adult Patients with Acute Lymphoblastic Leukemia
![Asparaginase Toxicities: Identification and Management in Patients With Acute Lymphoblastic Leukemia | ONS Asparaginase Toxicities: Identification and Management in Patients With Acute Lymphoblastic Leukemia | ONS](https://cjon.ons.org/sites/default/files/journal-images/Table2Huynh.png)